Catalyst Biosciences’ $60 Million Sale of Complement Portfolio

Martina Bellini
Tagged:

Orrick advised Catalyst Biosciences, Inc. on the deal.South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc. (NASDAQ: CBIO) announced the sale of its complement asset portfolio for $60…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now